Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
7.00
+0.18 (2.64%)
Oct 1, 2026, 11:17 AM EDT - Market open
Shattuck Labs Market Cap
Shattuck Labs has a market cap or net worth of $702.54 million as of October 1, 2026. Its market cap has increased by 365.47% in one year.
Market Cap
702.54M
Enterprise Value
496.91M
1-Year Change
365.47%
Ranking
Category
Stock Price
$7.00
ChartMarket Cap Chart
Since the IPO on October 9, 2020, Shattuck Labs's market cap has increased from $677.31M to $702.54M, an increase of 3.73%. That is a compound annual growth rate of 0.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 702.54M | 204.17% |
| Dec 31, 2025 | 230.97M | 299.85% |
| Dec 31, 2024 | 57.77M | -82.81% |
| Dec 29, 2023 | 336.08M | 244.71% |
| Dec 30, 2022 | 97.50M | -72.88% |
| Dec 31, 2021 | 359.52M | -83.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 689.15M |
| MiMedx Group | 680.70M |
| BlossomHill Therapeutics | 679.24M |
| DBV Technologies | 676.66M |
| Zevra Therapeutics | 673.41M |
| Nuvectis Pharma | 668.90M |
| Climb Bio | 660.52M |
| Silence Therapeutics | 650.26M |